rdf:type |
|
lifeskim:mentions |
umls-concept:C0001962,
umls-concept:C0002658,
umls-concept:C0012634,
umls-concept:C0020591,
umls-concept:C0030705,
umls-concept:C0036557,
umls-concept:C0038586,
umls-concept:C0040616,
umls-concept:C0332307,
umls-concept:C0563664,
umls-concept:C0687130,
umls-concept:C1705241,
umls-concept:C1705242,
umls-concept:C1707455,
umls-concept:C2603343,
umls-concept:C2741665
|
pubmed:issue |
6
|
pubmed:dateCreated |
2011-3-9
|
pubmed:abstractText |
Substance use disorder is one of the important mental health problems related to suicide, nearly equal with depressive disorder. However, it is unclear how differences of abused substances influence the suicide risk of individuals with substance use disorder in Japan. The purpose of the present study is to compare an estimated suicide risk among patients with alcohol, amphetamine, and sedative, hypnotic or anxiolytic use disorders.
|
pubmed:language |
jpn
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1341-8963
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
530-42
|
pubmed:meshHeading |
pubmed-meshheading:21387609-Alcoholism,
pubmed-meshheading:21387609-Amphetamine-Related Disorders,
pubmed-meshheading:21387609-Anti-Anxiety Agents,
pubmed-meshheading:21387609-Female,
pubmed-meshheading:21387609-Humans,
pubmed-meshheading:21387609-Hypnotics and Sedatives,
pubmed-meshheading:21387609-Male,
pubmed-meshheading:21387609-Middle Aged,
pubmed-meshheading:21387609-Risk Factors,
pubmed-meshheading:21387609-Substance-Related Disorders,
pubmed-meshheading:21387609-Suicide
|
pubmed:year |
2010
|
pubmed:articleTitle |
[A study on differences of suicide risk in substance use disorder patients by types of an abused substance: a comparison among alcohol, amphetamine, and sedative, hypnotic or anxiolytic use disorder patients].
|
pubmed:affiliation |
Department of Drug Dependence Research/Center for Suicide Prevention, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8553, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Research Support, Non-U.S. Gov't
|